Category for posts not assigned a category.
ECS Botanics is making bold moves in the medicinal cannabis space and the numbers prove it’s working. In an exclusive interview with ECS Botanics, Managing Director Nan-Maree Schoerie reveals how the company pivoted from wholesale supplier to top-ten consumer brand in under a year, now capturing over 50% of revenue from its own product line….
Providing existing customers with a consistent supply of quality cannabis must take priority over winning new contracts, ECS Botanics managing director Nan-Maree Schoerie has said, as she warned of the dangers of over-stretching the firm’s resources. She told shareholders that even though new contracts would “drive up the share price”, ECS risked losing business if…
ECS Botanics reported a net cash operating deficit of A$1.5 million in the three months to March 31 as the company continued to build the market presence of its in-house brands.The firm delivered Q3 revenue of $4.8m, up 1% on the second quarter and 19% higher than the previous corresponding period (pcp). Direct to consumer…
ECS Botanics has increased its loan facility with National Australia Bank by A$2 million as it prepares for the local and international launch of the Terphogz product line. It takes the total facility with NAB to $5.2m – all of which remains unused – with the funds set to support the launch of Terphogz in…
Australian medicinal cannabis producer ECS Botanics is taking its expansion plans global after securing a significant funding boost from one of Australia’s biggest banks. The Victorian-based cultivator announced on Monday it had increased its National Australia Bank loan facility by $2 million to a total of $5.2 million, while also securing an additional $400,000 for…
“Nan-Maree Schoerie of ECS Botanics (ASX: ECS) shares that the company has secured a $5.2 million loan facility from NAB. This funding will support ECS in expanding its B2C segment and launching its new turf product line. She appreciates the funding as it aids in rapid business growth.” Watch video or read transcript on Ausbiz
“Nan-Maree Schoerie elaborates on funding arrangement along with the plans for the company. ECS Botanics has added more than $100,000 into its accounts, thanks to a Victoria government manufacturing grant.” Watch video or read transcript on Ausbiz
“Nan-Maree Schoerie, Managing Director of ECS Botanics (ECS), discusses the fiscal performance of her company and her strategic plans to expand its market reach. Watch video or read transcript on Ausbiz
“Nan-Maree Schoerie, of ECS Botanics, reports the company’s revenue has seen a 78% surge. The outdoor cultivation area has grown by 60% and the firm has reported another quarter of positive net operating cash flow.” Watch video or read transcript on Ausbiz
“Nan-Maree Schoerie, from ECS Botanics (ECS), sheds light on the recent agreement with Elite Medical Solutions to retail its medicinal cannabis products.” Watch video or read transcript on Ausbiz
“ECS is launching a range of GMP-certified cannabidiol (CBD) and tetrahydrocannabinol (THC) pastilles and THC vapes.” Read full article on The Sentiment
“Amid optimism that cannabis’s ongoing slide will soon end, ASX-listed ECS Botanics has given an insight into why it defied the funk, to rise in 2023.” Read full article on the Australian Business Review
“Perth-headquartered medicinal cannabis company Little Green Pharma (LGP) is bullish on opportunities in Germany after the country legalised the drug on Friday with certain limitations, including personal possession of up to 25g, allowing three marijuana plants per household, and the establishment of non-commercial clubs for cultivation and distribution with caps on membership and volume.” Read…
“ECS Botanics Holdings, an Australian medical marijuana cultivator in Victoria, reported a significant jump in revenue to 7.3 million Australian dollars ($6.5 million) in its second fiscal quarter ending Dec. 31.” Read full article on MJBizDaily
“ECS Botanics Holdings (ASX:ECS) has inked a binding offtake agreement with UK-based Rokshaw for the supply of medicinal cannabis dried flower over the next three years.” Read full article on The Market Online
Introduction ECS Botanics Holding Ltd., a leading name in the organic cultivation and manufacturing of GMP medicinal cannabis products, recently hosted an insightful investor webinar. This event provided a comprehensive overview of the company’s operations, strategic initiatives, and future growth prospects. Here’s a detailed recap of the key points discussed during the webinar. Webinar Highlights…
2023/24 season update In 2023/24 ECS Botanics has been actively expanding its facilities and capabilities, demonstrating significant progress in both the cultivation and manufacturing of medicinal cannabis. This includes the continued strategic focus on using organic and regenerative agricultural practices to enhance product quality and environmental sustainability. Recent achievements and partnerships that ECS Botanics has…
On Tuesday, northern Victorian quiet achiever – the medicinal cannabis cultivator and manufacturer ECS Botanics (ASX:ECS) – revealed it secured a stunning five-year, $24 million deal to supply Perth-based MediCann Health with its top (medicinal cannabis dried flower) strain. The deal builds on the existing two-year contract and expects to deliver over four tonnes of dried cannabis flower…
